Speech-Language Pathologists in Fulton, MD Accepting Medicare

5 Speech-Language Pathologists found. Showing 1 - 5

Kerri Scriven Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9459 Ellsworth Ct, Fulton, MD 20759 Phone: 301-776-0092

Gisele Marie Morin-connolly Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11630 Scaggsville Rd, Fulton, MD 20759 Phone: 410-888-8800

Dr. Diana Newman Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8972 Tawes St, Fulton, MD 20759 Phone: 860-983-6942

Spring Into Speech Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7548 Morris St Unit 2, Fulton, MD 20759 Phone: 301-832-6269

Mrs. Brooke Springer, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7548 Morris St Unit 2, Fulton, MD 20759 Phone: 301-832-6269

News Archive

NFIX protein drives NSC differentiation toward oligodendrocytes

An international team of researchers has shown that NFIX, a protein that regulates neuronal stem cell activity (NSC), also has a role in driving NSC differentiation toward oligodendrocytes, a type of glial cell. These cells produce the myelin that surrounds and protects neurons.

V-chip could allow health care providers to do 50 different tests in one go

A new device about the size of a business card could allow health care providers to test for insulin and other blood proteins, cholesterol, and even signs of viral or bacterial infection all at the same time—with one drop of blood. Preliminary tests of the V-chip, created by scientists at The Methodist Hospital Research Institute and MD Anderson Cancer Center, were published last night by Nature Communications.

Dutasteride reduces risk of prostate cancer

There is good news for those at high risk for prostate cancer. The drug dutasteride which is manufactured by GlaxoSmithKline as the drug Avodart, has been found to reduce the risk of prostate cancer by a quarter. The drug is at present being used to treat enlarged prostates.

New breakthrough in chemical nanoengineering may help develop light-regulated therapeutic molecules

The scientific cooperation between chemists, biotechnologists and physicists from various Catalan institutes, headed by Pau Gorostiza, from the Institute for Bioengineering of Catalonia (IBEC), and Ernest Giralt, from the Institute for Research in Biomedicine (IRB Barcelona), has led to a breakthrough that will favor the development of light-regulated therapeutic molecules.

Avoiding boomeritis: Tips from Mayo Clinic Women's HealthSource

Orthopedic surgeons are seeing a wave of exercise-related injuries among baby boomers - a phenomenon dubbed "boomeritis."

Read more Medical News

› Verified 5 days ago